Bliss GVS Pharma Limited Recommended Final Dividend of 50% i.e. 50 Paisa per equity share on the face value of INR 1 each for the financial year ended March 31, 2024, subject to the approval of the shareholders in the forthcoming 39th Annual General Meeting of the Company to be held on July 25, 2024. If the final dividend, as recommended by the Board of Directors, is approved at the 39th AGM, payment of such dividend subject to deduction of tax at source will be made on or before August 24, 2024.